FOCUSED ON

IMPROVING ACCESS

Founded in 2018, Asegua Therapeutics LLC is committed to providing greater access to therapies. Asegua Therapeutics LLC has launched an authorized generic of EPCLUSA® (sofosbuvir/velpatasvir) and an authorized generic of HARVONI® (ledipasvir/sofosbuvir).

Asegua Therapeutics LLC is the provider of the authorized generic of EPCLUSA and the authorized generic of HARVONI

Please see full Prescribing Information for sofosbuvir/velpatasvir and ledipasvir/sofosbuvir, including BOXED WARNING.

This information is intended for US residents only. The information provided in this website is for educational purposes and not meant to replace a discussion or advice with a healthcare provider.

ASEGUA and the ASEGUA logo are trademarks of Asegua Therapeutics LLC. EPCLUSA, HARVONI, SUPPORT PATH and GILEAD are trademarks of Gilead Sciences, Inc., or one of its related companies and are used by permission. All other trademarks referenced herein are the property of their respective owners.

© 2019 Asegua Therapeutics LLC. All rights reserved. ADMP0727 01/19

Asegua Therapeutics LLC is an affiliate of Gilead Sciences Inc.